Align Technology, Inc. (ALGN)
$
141.96
+0.83 (0.58%)
Key metrics
Financial statements
Free cash flow per share
9.3476
Market cap
10.3 Billion
Price to sales ratio
2.5954
Debt to equity
0.0314
Current ratio
1.2268
Income quality
3.3265
Average inventory
245.2 Million
ROE
0.1129
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Align Technology, Inc. is a prominent medical device company known for designing, manufacturing, and marketing Invisalign clear aligners and iTero intraoral scanners, along with related services tailored for orthodontists, general practitioner dentists, and professionals involved in restorative and aesthetic dentistry. The company earned an interest income of $20,218,000.00 showcasing its financial investments. Additionally, it incurred an income tax expense of $187,597,000.00 indicating its tax obligations. With an operating income ratio of 0.15 the firm demonstrates its operational profitability margins. The gross profit stands at $2,799,159,000.00 highlighting the company's profitability from core operations, while the weighted average number of diluted shares outstanding is 74,993,000.00 reflecting potential dilution effects. Operating through two main segments—the Clear Aligner segment, which provides a range of treatment options for teenagers and younger patients, and the Scanners and Services segment, which offers advanced scanning solutions—the company serves a wide market that includes the United States, Switzerland, China, and beyond. The stock is priced at $199.31 positioning it in the higher-end market, with an average trading volume of 1,421,220.00 indicating moderate liquidity. Holding a mid-range market capitalization of $10,290,169,344.00 Align Technology, Inc. is recognized as a steady performer in the medical technology field. It is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape and driving innovation and growth within the Healthcare sector. The diverse product offerings and reliable financial performance underscore Align Technology’s pivotal role in shaping the future of orthodontic and dental treatment solutions.
Is Align Technology, Inc. (ALGN) a good investment?
Investing in Align Technology, Inc. (ALGN) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bullish outlook. Always conduct your own research before investing.
What is Align Technology, Inc. (ALGN)'s stock forecast?
Analysts predict Align Technology, Inc. stock to fluctuate between $127.70 (low) and $262.87 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Align Technology, Inc.'s market capitalization?
As of 2025-08-29, Align Technology, Inc.'s market cap is $10,290,169,344, based on 72,486,400 outstanding shares.
How does Align Technology, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Align Technology, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Align Technology, Inc. (ALGN) stock?
To buy Align Technology, Inc. (ALGN) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ALGN. Place an order (Market, Limit, etc.).
What is the best time to invest in Align Technology, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Align Technology, Inc. perform in the last earnings report?
Revenue: $3,999,012,000 | EPS: $5.63 | Growth: -3.26%.
Where can I find Align Technology, Inc.'s investor relations reports?
Visit https://www.aligntech.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Align Technology, Inc.?
You can explore historical data from here
What is the all-time high and low for Align Technology, Inc. stock?
All-time high: $737.45 (2021-09-23) | All-time low: $127.70 (2025-07-31).
What are the key trends affecting Align Technology, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?
prnewswire.com
NEW YORK , Aug. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Align Technology, Inc. ("Align" or the "Company") (NASDAQ: ALGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
globenewswire.com
NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Align Technology, Inc. (“Align” or the “Company”) (NASDAQ: ALGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
globenewswire.com
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Align (ALGN) To Contact Him Directly To Discuss Their Options
globenewswire.com
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Align Technology, Inc. (“Align” or the “Company”) (NASDAQ: ALGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
businesswire.com
SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the filing of patent infringement lawsuits against Angelalign Technology, Inc. (“Angel”) (Hong Kong Stock Exchange: 6699.HK), a Shanghai-based manufacturer.
businesswire.com
SAN JOSE, Calif. & TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the filing of patent infringement lawsuits against Angelalign Technology, Inc. (“Angel”) (Hong Kong Stock Exchange: 6699.HK), a Shanghai-based manufacturer.
businesswire.com
LOS ANGELES--(BUSINESS WIRE)---- $INSP--ALGN Investors Have Opportunity to Join Align Technology, Inc. Fraud Investigation with the Schall Law Firm.
zacks.com
Align Technology ( ALGN ), maker of the clear "smile straightener" Invisalign, reported Q2 2025 adjusted earnings per share (EPS) of $2.49, up 3.3% from the year-ago level. But the profit figure missed the Zacks Consensus Estimate by 3.1%.
globenewswire.com
SAN DIEGO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Align Technology, Inc. (NASDAQ: ALGN) focused on whether Align Technology and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.
See all news
